Prakash C - Search Results

1

Metabolism and excretion of a new antipsychotic drug, ziprasidone, in humans.

Prakash C, Kamel A, Gummerus J, Wilner K. Prakash C, et al. Drug Metab Dispos. 1997 Jul;25(7):863-72. Drug Metab Dispos. 1997. PMID: 9224781 Clinical Trial.

2

Metabolism and excretion of the novel antipsychotic drug ziprasidone in rats after oral administration of a mixture of 14C- and 3H-labeled ziprasidone.

Prakash C, Kamel A, Anderson W, Howard H. Prakash C, et al. Drug Metab Dispos. 1997 Feb;25(2):206-18. Drug Metab Dispos. 1997. PMID: 9029052

3

Characterization of the novel benzisothiazole ring-cleaved products of the antipsychotic drug ziprasidone.

Prakash C, Kamel A, Cui D. Prakash C, et al. Drug Metab Dispos. 1997 Jul;25(7):897-901. Drug Metab Dispos. 1997. PMID: 9224786

4

Metabolism and excretion of a novel antianxiety drug candidate, CP-93,393, in Long Evans rats. Differentiation of regioisomeric glucuronides by LC/MS/MS.

Prakash C, Soliman V. Prakash C, et al. Drug Metab Dispos. 1997 Nov;25(11):1288-97. Drug Metab Dispos. 1997. PMID: 9351906

5

Determination of the substance P receptor antagonist CP-122,721 in plasma by narrow-bore high-performance liquid chromatography-ionspray tandem mass spectrometry.

Kamel A, Prakash C. Kamel A, et al. Among authors: prakash c. J Chromatogr B Biomed Sci Appl. 1997 Oct 24;700(1-2):139-46. doi: 10.1016/s0378-4347(97)00315-0. J Chromatogr B Biomed Sci Appl. 1997. PMID: 9390723

6

Metabolism and excretion of a new antianxiety drug candidate, CP-93,393, in cynomolgus monkeys: identification of the novel pyrimidine ring cleaved metabolites.

Prakash C, Cui D. Prakash C, et al. Drug Metab Dispos. 1997 Dec;25(12):1395-406. Drug Metab Dispos. 1997. PMID: 9394030

7

Metabolism and excretion of a new anxiolytic drug candidate, CP-93, 393, in healthy male volunteers.

Prakash C, Cui D, Baxter JG, Bright GM, Miceli J, Wilner K. Prakash C, et al. Drug Metab Dispos. 1998 May;26(5):448-56. Drug Metab Dispos. 1998. PMID: 9571226

8

Identification of the major human liver cytochrome P450 isoform(s) responsible for the formation of the primary metabolites of ziprasidone and prediction of possible drug interactions.

Prakash C, Kamel A, Cui D, Whalen RD, Miceli JJ, Tweedie D. Prakash C, et al. Br J Clin Pharmacol. 2000;49 Suppl 1(Suppl 1):35S-42S. doi: 10.1046/j.1365-2125.2000.00151.x. Br J Clin Pharmacol. 2000. PMID: 10771452 Free PMC article.

9

Narrow-bore high-performance liquid chromatography in combination with ionspray tandem mass spectrometry for the determination of the substance P receptor antagonist ezlopitant and its two active metabolites in plasma.

Kamel A, Prakash C, Saverino C, Obach B, Fouda H. Kamel A, et al. Among authors: prakash c. J Chromatogr B Biomed Sci Appl. 2000 Oct 1;748(1):179-88. doi: 10.1016/s0378-4347(00)00361-3. J Chromatogr B Biomed Sci Appl. 2000. PMID: 11092597

10

Metabolism, pharmacokinetics, and excretion of a highly selective N-methyl-D-aspartate receptor antagonist, traxoprodil, in human cytochrome P450 2D6 extensive and poor metabolizers.

Johnson K, Shah A, Jaw-Tsai S, Baxter J, Prakash C. Johnson K, et al. Among authors: prakash c. Drug Metab Dispos. 2003 Jan;31(1):76-87. doi: 10.1124/dmd.31.1.76. Drug Metab Dispos. 2003. PMID: 12485956

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

519 results

Search Page

Filters